Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.18.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.58.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDCNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JR.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.26.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used